» Articles » PMID: 26733416

RPS23RG1 Reduces Aβ Oligomer-induced Synaptic and Cognitive Deficits

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jan 7
PMID 26733416
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is the most common form of dementia in the elderly. It is generally believed that β-amyloidogenesis, tau-hyperphosphorylation, and synaptic loss underlie cognitive decline in AD. Rps23rg1, a functional retroposed mouse gene, has been shown to reduce Alzheimer's β-amyloid (Aβ) production and tau phosphorylation. In this study, we have identified its human homolog, and demonstrated that RPS23RG1 regulates synaptic plasticity, thus counteracting Aβ oligomer (oAβ)-induced cognitive deficits in mice. The level of RPS23RG1 mRNA is significantly lower in the brains of AD compared to non-AD patients, suggesting its potential role in the pathogenesis of the disease. Similar to its mouse counterpart, human RPS23RG1 interacts with adenylate cyclase, activating PKA/CREB, and inhibiting GSK-3. Furthermore, we show that human RPS23RG1 promotes synaptic plasticity and offsets oAβ-induced synaptic loss in a PKA-dependent manner in cultured primary neurons. Overexpression of Rps23rg1 in transgenic mice consistently prevented oAβ-induced PKA inactivation, synaptic deficits, suppression of long-term potentiation, and cognitive impairment as compared to wild type littermates. Our study demonstrates that RPS23RG1 may reduce the occurrence of key elements of AD pathology and enhance synaptic functions to counteract oAβ-induced synaptic and cognitive deficits in AD.

Citing Articles

Comment on "Activation of the Omega-3 Fatty Acid Receptor GPR120 Protects against Focal Cerebral Ischemic Injury by Preventing Inflammation and Apoptosis in Mice".

Brown J, Murphy K, OConnell T, Lesne S J Immunol. 2022; 209(7):1229-1233.

PMID: 36167357 PMC: 9756940. DOI: 10.4049/jimmunol.2200151.


Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice.

Wang C, Zhang Y, Zhao D, Huo Y, Xie J, Zhang X Neuropsychopharmacology. 2022; 47(12):2042-2050.

PMID: 35821069 PMC: 9556769. DOI: 10.1038/s41386-022-01373-7.


RPS23RG1 Is Required for Synaptic Integrity and Rescues Alzheimer's Disease-Associated Cognitive Deficits.

Zhao D, Meng J, Zhao Y, Huo Y, Liu Y, Zheng N Biol Psychiatry. 2018; 86(3):171-184.

PMID: 30292394 PMC: 6389446. DOI: 10.1016/j.biopsych.2018.08.009.


Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.

Du Y, Zhao Y, Li C, Zheng Q, Tian J, Li Z J Exp Med. 2018; 215(6):1665-1677.

PMID: 29739836 PMC: 5987914. DOI: 10.1084/jem.20171193.


ER-associated degradation regulates Alzheimer's amyloid pathology and memory function by modulating γ-secretase activity.

Zhu B, Jiang L, Huang T, Zhao Y, Liu T, Zhong Y Nat Commun. 2017; 8(1):1472.

PMID: 29133892 PMC: 5684335. DOI: 10.1038/s41467-017-01799-4.


References
1.
Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

2.
Zhao X, Wang W, Tan J, Huang J, Zhang X, Zhang B . Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. J Neurosci. 2010; 30(4):1512-22. PMC: 6633795. DOI: 10.1523/JNEUROSCI.3699-09.2010. View

3.
Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

4.
Nakanishi N, Tu S, Shin Y, Cui J, Kurokawa T, Zhang D . Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci. 2009; 29(16):5260-5. PMC: 2703294. DOI: 10.1523/JNEUROSCI.1067-09.2009. View

5.
Zheng H, Koo E . Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener. 2011; 6(1):27. PMC: 3098799. DOI: 10.1186/1750-1326-6-27. View